Clinical trial
Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis
NCT00434330 · Affymax, Industry · Completed
Key facts
| NCT number | NCT00434330 |
|---|---|
| Title | Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis |
| Official title | A Phase 2, Open-Label, Multi-Center, Dose Finding Study of the Safety, Pharmacodynamics, and Pharmacokinetics of Peginesatide for the Maintenance Treatment of Anemia in Hemodialysis Patients Previously Treated With Epoetin |
| Lead sponsor | Affymax, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Chronic Kidney Disease, Chronic Renal Failure |
| Intervention type | Drug |
| Interventions | peginesatide |
| Enrollment | 91 |
| Start date | Dec 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Feb 13, 2007 |
| Last update posted | Jun 29, 2012 |
| Countries | Bulgaria, Romania, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: